BRL-44408
Chemical compound (drug)
From Wikipedia, the free encyclopedia
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the α2A-adrenergic receptor.[1] It has been suggested as having potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.[2]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H17N3 |
| Molar mass | 215.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |